Free Trial
TSE:MDNA

Medicenna Therapeutics (MDNA) Stock Price, News & Analysis

Medicenna Therapeutics logo
C$0.85 +0.02 (+2.41%)
As of 03:59 PM Eastern

About Medicenna Therapeutics Stock (TSE:MDNA)

Key Stats

Today's Range
C$0.84
C$0.92
50-Day Range
C$0.83
C$1.22
52-Week Range
C$0.78
C$2.63
Volume
31,106 shs
Average Volume
47,900 shs
Market Capitalization
C$63.59 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Medicenna Therapeutics Corp is a Canada based immuno-oncology company. Its principal business activity is the development and commercialization of Empowered Cytokines and Superkines for the treatment of cancer. The company is engaged in developing Interleukin-4 Empowered Cytokines that specifically target the Interleukin-4 Receptor which is over-expressed by 20 different cancers, cancer stem cells and immunosuppressive cells of the tumor microenvironment. The have the potential to purge the tumor and un-blind the immune system to cancer thereby altering the treatment paradigm for a large majority of cancer patients.

Receive MDNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medicenna Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

MDNA Stock News Headlines

Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.
Medicenna Therapeutics reports clinical data from ABILITY-1 study of MDNA11
Medicenna’s MDNA11 Shows Promising Cancer Treatment Results
See More Headlines

MDNA Stock Analysis - Frequently Asked Questions

Medicenna Therapeutics' stock was trading at C$1.65 at the beginning of 2025. Since then, MDNA stock has decreased by 48.5% and is now trading at C$0.85.
View the best growth stocks for 2025 here
.

Shares of MDNA stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Medicenna Therapeutics investors own include Manulife Financial (MFC), Gilead Sciences (GILD), OPKO Health (OPK), Air Canada (AC), Athersys (ATHX), Birchcliff Energy (BIR) and Canadian Natural Resources (CNQ).

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
TSE:MDNA
CIK
N/A
Fax
N/A
Employees
20
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$25.98 million
Net Margins
-533,640.00%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$4.87 thousand
Price / Sales
13,062.39
Cash Flow
C$0.74 per share
Price / Cash Flow
1.15
Book Value
C$0.26 per share
Price / Book
3.26

Miscellaneous

Free Float
N/A
Market Cap
C$63.59 million
Optionable
Not Optionable
Beta
1.21
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (TSE:MDNA) was last updated on 6/30/2025 by MarketBeat.com Staff
From Our Partners